Interim results from the phase 3 FRONTIER4 extension show Novo Nordisk’s denecimig (Mim8) provided low bleeding rates and a favorable…
Merck published a Science paper describing a new, scalable biocatalytic synthesis for enlicitide decanoate — an investigational oral PCSK9 inhibitor.…
Lubiprostone — a common prescription for chronic constipation — slowed decline in kidney function in moderate chronic kidney disease (CKD)…
New preclinical work from Helmholtz Munich describes a conjugate drug that uses GLP‑1/GIP receptors to carry a pan‑PPAR activator (lanifibranor)…
The FDA has granted Fast Track designation to tazbentetol, an oral drug from Spinogenix that uses a synaptic-regenerative mechanism to…
Takeda reported that its Phase 2/3 trial TAK-881-3001 showed TAK-881 produced essentially the same immunoglobulin G (IgG) exposure as HYQVIA—a…
The ORION analysis from Novo Nordisk used population-adjusted indirect comparison methods to contrast oral semaglutide 25 mg tablets with Eli…
NIH scientists report a novel opioid, DFNZ, that in rodents produced sustained pain relief for over two hours while, unusually…
Clinical trial data show solriamfetol can modestly but reliably increase wakefulness in people with shift work disorder who start work…
Efzimfotase alfa, a next‑generation enzyme replacement therapy from AstraZeneca Rare Disease, produced a clear, statistically significant bone‑health signal in treatment‑naïve…
Novartis’ Phase III APPLAUSE‑IgAN trial published in the New England Journal of Medicine and presented at the 2026 World Congress…
New animal research from Baylor College of Medicine shows that metformin—at doses typically used in people—lowers blood glucose by suppressing…
